bucladesine has been researched along with ATLL in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Granot, Y; Isakov, N; Tamir, A | 1 |
1 other study(ies) available for bucladesine and ATLL
Article | Year |
---|---|
Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Humans; Indoles; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Activation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Lymphoma, T-Cell; Maleimides; Mice; Mitogen-Activated Protein Kinases; Mitogens; Molecular Sequence Data; Muromonab-CD3; Nerve Tissue Proteins; Peptide Fragments; Phosphorylation; Protein Kinase C; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1996 |